Diabetic Instability and Celiac Disease: A frequent association to keep in mind

F. Andreelli,I. Plotton,J. Riou,C. Thivolet

DOI: https://doi.org/10.2337/diacare.21.12.2192

1998-12-01

Diabetes Care

Abstract:allowing HOMA to be used with either immunoreactive insulin or specific insulin assays, and a model of renal glucose losses, allowing its use in more hyperglycemic states. These modifications provide a more accurate representation of physiology and successfully predict the homeostatic responses to an intravenous glucose infusion. The use of the current HOMA model performs well in comparison with several tests of insulin sensitivity, including the intravenous glucose tolerance test, and with minimal model analysis and the short insulin tolerance test of Bonora (6) and tests of fJ-cell function (7), including the hyperglycemic clamp (8), the oral glucose tolerance test (9), and the frequently sampled intravenous glucose tolerance test (FSIVGTT) (7).